Oral administration to diet-induced-obese mice for ~10 days reduces fat mass without altering food intake, decreases adipocyte size, restores insulin sensitivity, and increases adipose NAD and SAM levels [2]
You can administer an intramuscular injection in your deltoid muscle, upper thigh, or outer hip
BPC-157 Dosage Published BPC-157 protocols use 200500 g per dose, given one to three times daily
Long-Term Protocols: The most clinically relevant studies evaluated subcutaneous doses of 0.25 mg (250 mcg), 0.5 mg (500 mcg), and 1 mg (1,000 mcg) administered daily for 24 weeks
This distinction is particularly useful in experimental designs where separation of adipose-specific signaling from systemic endocrine effects is required
Compound Reference Data Compound: AOD-9604 CAS Number: 221231-10-3 Molecular Formula: C78H123N23O23S2 Molecular Weight: 1815.07 g/mol Sequence: YLRIVQCRSVEGSCGF (residues 177191 of human growth hormone) Synonyms: AOD9604, Anti-Obesity Drug 9604, hGH fragment 176-191 (modified) Selected Published Studies Published research on AOD-9604 consists of animal-model and in vitro studies